I-Mab (IMAB) DCF Valuation

I-Mab (IMAB) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

I-Mab (IMAB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (IMAB) DCF Calculator enables you to evaluate I-Mab's valuation using real-world financial data while offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 4.1 211.3 12.1 -30.4 3.8 1.9 1.0 .5 .3 .1
Revenue Growth, % 0 5042.23 -94.29 -351.7 -112.48 -48.57 -48.57 -48.57 -48.57 -48.57
EBITDA -199.4 23.1 -281.9 -266.3 -166.1 -.7 -.4 -.2 -.1 -.1
EBITDA, % -4850.46 10.91 -2337.41 877.46 -4384.57 -37.82 -37.82 -37.82 -37.82 -37.82
Depreciation 1.3 1.7 1.9 3.5 3.3 .5 .2 .1 .1 .0
Depreciation, % 32.77 0.82604 15.65 -11.44 86.63 24.89 24.89 24.89 24.89 24.89
EBIT -200.7 21.3 -283.8 -269.8 -169.3 -.7 -.4 -.2 -.1 -.1
EBIT, % -4883.23 10.08 -2353.06 888.9 -4471.2 -37.98 -37.98 -37.98 -37.98 -37.98
Total Cash 160.2 656.3 585.9 472.6 313.7 1.2 .6 .3 .2 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.1 17.9 39.3 .7 .3
Account Receivables, % 26.62 8.46 325.88 -2.17 9.17
Inventories -7.7 -57.9 3.7 -11.0 1.8 -.1 .0 .0 .0 .0
Inventories, % -186.23 -27.41 30.94 36.23 46.23 -2.8 -2.8 -2.8 -2.8 -2.8
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 0 0 0 0 0 0 0 0 0 0
Capital Expenditure -1.7 -1.1 -4.1 -6.3 -.2 -.3 -.2 -.1 .0 .0
Capital Expenditure, % -40.8 -0.5191 -34 20.68 -5.79 -16.22 -16.22 -16.22 -16.22 -16.22
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -205.3 20.8 -283.4 -269.9 -169.3 -.7 -.4 -.2 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -199.0 54.9 -368.7 -219.3 -178.7 1.0 .0 .0 .0 .0
WACC, % 9.39 9.39 9.39 9.39 9.39 9.39 9.39 9.39 9.39 9.39
PV UFCF
SUM PV UFCF .9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 1
Net Debt -275
Equity Value 276
Diluted Shares Outstanding, MM 83
Equity Value Per Share 3.31

What You Will Receive

  • Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real I-Mab (IMAB) financials.
  • Authentic Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Flexible Forecasting: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect I-Mab’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for clarity and ease of use, complete with step-by-step guidance.

Key Features

  • Comprehensive I-Mab Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: Clear and informative charts and summaries to illustrate your valuation findings.
  • Designed for All Levels: An intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered I-Mab (IMAB) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for I-Mab’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for I-Mab (IMAB)?

  • Accurate Data: Real I-Mab financials provide dependable valuation outcomes.
  • Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Pre-built calculations save you from starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate design and step-by-step guidance ensure accessibility for all users.

Who Should Use I-Mab (IMAB)?

  • Investors: Gain insights and make informed decisions with a comprehensive analysis of I-Mab's pipeline and performance.
  • Pharmaceutical Analysts: Streamline your evaluations with detailed reports on I-Mab's drug development progress.
  • Consultants: Easily modify templates for presentations or strategic reports focused on I-Mab's market positioning.
  • Healthcare Enthusiasts: Enhance your knowledge of biopharmaceutical trends through I-Mab's innovative therapies.
  • Educators and Students: Utilize I-Mab's case studies as a practical resource in pharmaceutical and biotechnology courses.

What the Template Contains

  • Historical Data: Includes I-Mab’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate I-Mab’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of I-Mab’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.